A 45 year-old woman with a breast mass. Core needle biopsy was - - PowerPoint PPT Presentation

▶
a 45 year old woman with a breast mass core needle biopsy
SMART_READER_LITE
LIVE PREVIEW

A 45 year-old woman with a breast mass. Core needle biopsy was - - PowerPoint PPT Presentation

Feb 19, 2023 387 likes •841 views

Case 1: A 45 year-old woman with a breast mass. Core needle biopsy was performed. DIAGNOSIS? ER/PR - AMGA,excision recommended Partial mastectomy, periphery of mass Close to center of mass Center of mass Matrix producing ca arising in

slide-1
SLIDE 1

Case 1: A 45 year-old woman with a breast

  • mass. Core needle biopsy was

performed.

slide-2
SLIDE 2
slide-3
SLIDE 3
slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11
slide-12
SLIDE 12

DIAGNOSIS? ER/PR -

slide-13
SLIDE 13
slide-14
SLIDE 14

AMGA,excision recommended

slide-15
SLIDE 15

Partial mastectomy, periphery of mass

slide-16
SLIDE 16

Close to center of mass

slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21

Center of mass

slide-22
SLIDE 22
slide-23
SLIDE 23
slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26

Matrix producing ca arising in association with MGA, AMGA and in situ carcinoma Triple negative, Ki-67 10-50%

slide-27
SLIDE 27

History of prior excision of a breast mass (8 years earlier) diagnosed as MGA. Slides were requested for review

slide-28
SLIDE 28

Prior excision of a breast mass, 8 years earlier.

slide-29
SLIDE 29
slide-30
SLIDE 30
slide-31
SLIDE 31
slide-32
SLIDE 32
slide-33
SLIDE 33

Review Dx: AMGA, involving margins of resection

slide-34
SLIDE 34

Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma

The American Journal of Surgical Pathology. 32(4):544-552, APR 2008

Ibrahim Khalifeh; Constance Albarracin; Leslie Diaz; Fraser Symmans; Mary Edgerton; Rosa Hwang; Nour Sneige

slide-35
SLIDE 35

Clinical, Histopathologic, and Immunohistochemical Features

  • f Microglandular Adenosis and Transition Into In Situ and

Invasive Carcinoma

Khalifeh et al: AJSP 32(4):544-552, APR 2008

  • 108 cases (MDACC cases between 1983 -2007 that had a diagnosis
  • f MGA). Of the 108 cases, 65 cases had available material for

review.

  • Eleven out of 65 cases qualified to have an MGA component;

remaining 54 cases were classified as adenosis (myoepi. present).

  • Out of the 11 MGA patients: 3 patients with uncomplicated MGA

2 had AMGA 6 had MGACA.

slide-36
SLIDE 36

Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma

Khalifeh et al: AJSP, 32(4):544-552, 2008

Multiple invasive histologic components were identified in each of the MGACA cases. All tumors had strong and diffuse CK8/18 and EGFR expression but no ER/PR, HER2 (ie, triple negative), or CK5/6 expression. C-kit was focally expressed in 2 of the MGACAs. Ki-67 and p53 labeling indices increased with tumor progressions (<3% in all MGAs, 5% to 10% in the AMGAs, and >30% in MGACAs).

slide-37
SLIDE 37

Adenosis with infiltrating growth- mimicking MGA

Small glands with open lumen distributing randomly. The lining cells have abundant clear cytoplasm and occasional luminal secretions mimicking MGA (A). SMA highlighting the myoepithelial layer in the infiltrative adenosis (B).

slide-38
SLIDE 38

Uncomplicated MGA

Glands lined by single layer of epithelial cells showing abundant vacuolated cytoplasm and their lumen is open and filled with eosinophilic secretions (A). The glands of MGA strongly express S-100, and SMA confirms the absence of the myoepithelial layer (B).

slide-39
SLIDE 39

MGACA with in situ component showing expansile glands with obliterated lumens ( C) or severe cytologic atypia with frequent apoptosis and mitosis (D) MGACA with invasive component AMGA Packed complex glands with nuclear hyperchro masia

slide-40
SLIDE 40

Multiple histologic invasive components identified even in the single case: duct- forming (A), clear cell (B), sarcomatoid (C), matrix producing (D), basal-like (E) with bone metastasis (F), aciniclike (G), and adenoid cystic components (H)

slide-41
SLIDE 41
  • A. Diffuse S-100 expression in the

whole spectrum from uncomplicated MGA to AMGA ending with MGACA

  • B. Diffuse CK8/18 expression in the

uncomplicated MGA and AMGA

  • C. Diffuse EGFR expression in the

uncomplicated MGA (upper right corner) and MGACA

slide-42
SLIDE 42
  • A. Ki-67 labeling index in the uncomplicated MGA component (top
  • f the picture), in comparison with AMGA (bottom of the picture)

and MGACA (in the right lower corner).

  • B. p53 labeling index in the uncomplicated MGA component

(bottom of the picture), in comparison with AMGA (top of the picture) and MGACA (in the right lower corner).

slide-43
SLIDE 43

MGA and Transition Into In Situ and Invasive Carcinoma -

Khalifeh et al: AJSP, 32(4):544-552, 2008

In a follow-up ranging from 14 days to 8 years: None of the MGA cases recurred. One of the AMGA cases recurred as invasive ca in a background of AMGA after 8 years following incomplete excision of the lesion. Of 6 MGACA cases: 3 (50%) required multiple consecutive resections ending up with mastectomy due to involved margins by invasive or in situ ca.; 2 (34%) developed metastasis and died of disease.

slide-44
SLIDE 44

Conclusions

  • Our data showed that Ki-67 and p53 expression, in

conjunction with the morphologic features, could be a reliable marker to distinguish MGA from AMGA and MGACA.

  • Although 11 tumors were only included in our study,

64% of the tumors were carcinomas arising in MGA. This high incidence of MGACA may not represent the actual frequency of MGAs progressing into carcinoma and is likely due to referral bias in our institution. Nonetheless, the high association of carcinoma with MGA necessitates complete excision of MGA to rule

  • ut invasion.